Clinical activity of BMS-986365 (CC-94676), a dual androgen receptor (AR) ligand-directed degrader and antagonist, in heavily pretreated patients (pts) with metastatic castrationresistant prostate cancer (mCRPC) Meeting Abstract


Authors: Rathkopf, D.; Patel, M. R.; Choudhury, A. D.; Rasco, D.; Lakhani, N. J.; Hawley, J.; Srinivas, S.; Aparicio, A.; Narayan, V.; Runcie, K.; Emamekhoo, H.; Reichert, Z.; Nguyen, H.; Wells, A.; Kandimalla, R.; Suryawanshi, S.; Wu, J.; Arora, V.; Pourdehnad, M.; Armstrong, A. J.
Abstract Title: Clinical activity of BMS-986365 (CC-94676), a dual androgen receptor (AR) ligand-directed degrader and antagonist, in heavily pretreated patients (pts) with metastatic castrationresistant prostate cancer (mCRPC)
Meeting Title: ESMO Congress 2024
Journal Title: Annals of Oncology
Volume: 35
Issue: Suppl. 2
Meeting Dates: 2024 Sep 13-17
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2024-09-01
Start Page: S962
End Page: S963
Language: English
ACCESSION: WOS:001326612902219
DOI: 10.1016/j.annonc.2024.08.1678
PROVIDER: wos
Notes: Meeting Abstract: 1597MO -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dana Elizabeth Rathkopf
    272 Rathkopf